Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea

ClinicalTrials.gov ID: NCT02019589

Public ClinicalTrials.gov record NCT02019589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding After Administration of TX-12-002-HR in Estrogen-Primed Women With Secondary Amenorrhea

Study identification

NCT ID
NCT02019589
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
TherapeuticsMD
Industry
Enrollment
6 participants

Conditions and interventions

Interventions

  • Progesterone Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2014
Primary completion
Oct 30, 2014
Completion
Oct 30, 2014
Last update posted
May 7, 2018

2014

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Precision Trials/New Horizons Women's Care Chandler Arizona 85224
Precision Clinical Trials/Arizona Wellness Center for Women Phoenix Arizona 85032
Visions Clinical Research Tucson Arizona 85712
California Family Health Council Berkeley California 94710
California Family Health Council Los Angeles California 90010
Clinical Research Consulting Milford Connecticut 06460
Nature Coast Clinical Research Crystal River Florida 34429
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409
Cypress Medical Research Center Wichita Kansas 67226
Women's Clinic of Lincoln, P.C. Lincoln Nebraska 68510
Lawrence OB-Gyn Clinical Research Lawrenceville New Jersey 08648
Suffolk OBGYN Port Jefferson New York 11777
Wake Research Associates Raleigh North Carolina 27615
Lyndhurst Clinical Research Winston-Salem North Carolina 27103
University of Cincinnati Physicians Company Cincinnati Ohio 45229
HWC Women's Research Center Englewood Ohio 45322
Vista Clinical Research Columbia South Carolina 29201
Chattanooga Medical Research Chattanooga Tennessee 37404
Methodist Charlton Medical Center DeSoto Texas 75115
The Woman's Hospital of Texas Clinical Research Center Houston Texas 77054
PRO/Salt Lake Women's Center Sandy City Utah 84070
Tidewater Clinical Research Virginia Beach Virginia 23456

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02019589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02019589 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →